Sector dividends Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 185.69 CHF | +4.07% |
|
+0.22% | - |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.94% | 1.07% | 35.02x | 4.44x | 6.15x | 19.02x | 26.4x | 50.44B | ||
| -.--% | -.--% | -23.93x | 18.81x | 350.56x | -22.64x | -21.92x | 40.63B | ||
| -.--% | -.--% | 25.43x | 4.82x | 2.81x | 12.14x | 18.5x | 34.88B | ||
| -.--% | -.--% | 46.36x | 6.78x | 4.58x | 29.24x | 34.53x | 33.67B | ||
| 0.43% | 0.46% | 26.73x | 2.18x | 7.84x | 19.68x | 23.09x | 26.29B | ||
| -.--% | -.--% | 31.59x | 15.74x | 5.09x | 23.2x | 24.32x | 15.29B | ||
| -.--% | -.--% | -17.76x | 265.44x | 11.63x | -17.23x | -16.43x | 10.62B | ||
| 1.12% | 1.31% | 23.89x | 2.5x | 2.03x | 8.94x | 14.15x | 13.74B | ||
| -.--% | -.--% | 23.89x | 1.33x | 1.9x | 11.51x | 13.08x | 12.93B | ||
| -.--% | -.--% | -33.54x | 10.17x | 128.5x | -36.58x | -63.65x | 12.08B | ||
| 0.45% | 0.45% | 61.07x | 5.11x | 9.12x | 25.9x | 28.32x | 11.09B | ||
| -.--% | -.--% | -30.79x | 27.21x | 7.33x | 179.73x | -567.79x | 11.04B | ||
| -.--% | -.--% | -30.95x | 8.95x | 993.44x | -26.34x | -25.81x | 10.01B | ||
| -.--% | -.--% | -33.78x | 8.7x | 100.04x | -22.44x | -21.64x | 9.79B | ||
| -.--% | -.--% | -21.91x | 8.29x | 2563.75x | -18.59x | -17.65x | 9.29B | ||
| -.--% | -.--% | -140.43x | 4.86x | 5.49x | 29.1x | 166.36x | 8.96B | ||
| -.--% | -.--% | 35.15x | - | 16.23x | 28.96x | 31.37x | 8.85B | ||
| -.--% | -.--% | -15.6x | 9.59x | - | -12.9x | -13.65x | 8.44B | ||
| Average | 0.16% | 0.18% | -2.20x | 23.82x | 248.03x | 12.82x | -20.47x | 18.22B | |
| Weighted average by Cap. | 0.24% | 0.27% | 8.79x | 16.95x | 162.47x | 12.16x | -6.98x |
Select your edition
All financial news and data tailored to specific country editions
















